Anti-phospho-PRKACA, (Thr197) (cAMP-dependent Protein Kinase Catalytic Subunit alpha, PKA C-alpha,

Anti-phospho-PRKACA, (Thr197) (cAMP-dependent Protein Kinase Catalytic Subunit alpha, PKA C-alpha,
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
P9103-22Y.20 20 µl - -

3 - 19 Werktage*

462,00 €
P9103-22Y.100 100 µl - -

3 - 19 Werktage*

834,00 €
 
The second messenger cyclic AMP (cAMP) activates cAMP-dependent protein kinase (PKA or cAPK) in... mehr
Produktinformationen "Anti-phospho-PRKACA, (Thr197) (cAMP-dependent Protein Kinase Catalytic Subunit alpha, PKA C-alpha,"
The second messenger cyclic AMP (cAMP) activates cAMP-dependent protein kinase (PKA or cAPK) in mammalian cells and controls many cellular mechanisms such as gene transcription, ion transport, and protein phosphorylation (1). Inactive PKA is a heterotetramer composed of a regulatory subunit (R) dimer and a catalytic subunit (C) dimer. In this inactive state, the pseudosubstrate sequences on the R subunits block the active sites on the C subunits. Three C subunit isoforms (C-a, C-b, and C-y) and two families of regulatory subunits (RI and RII) with distinct cAMP binding properties have been identified. The two R families exist in two isoforms, a and b (RI-a, RI-b, RII-a, and RII-b). Upon binding of cAMP to the R subunits, the autoinhibitory contact is eased and active monomeric C subunits are released. PKA shares substrate specificity with Akt (PKB) and PKC, which are characterized by an arginine at position -3 relative to the phosphorylated serine or threonine residue (2). Substrates that present this consensus sequence and have been shown to be phosphorylated by PKA are Bad (Ser155), CREB (Ser133), and GSK-3 (GSK-3a Ser21 and GSK-3b Ser9) (3-5). In addition, combined knock-down of PKA C-a and -b blocks cAMP-mediated phosphorylation of Raf (Ser43 and Ser259) (6). Autophosphorylation and phosphorylation by PDK-1 are two known mechanisms responsible for phosphorylation of the C subunit at Thr197 (7). Applications: Suitable for use in Western Blot. Other applications not tested. Recommended Dilution: Western Blot: 1:1000, incubate membrane with diluted antibody in 5% BSA, 1X TBS, 0.1% Tween-20 at 4°C with gentle shaking, overnight., Optimal dilutions to be determined by the researcher. Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Schlagworte: EC=2.7.11.11, Anti-cAMP-dependent protein kinase catalytic subunit alpha
Hersteller: United States Biological
Hersteller-Nr: P9103-22Y

Eigenschaften

Anwendung: WB
Antikörper-Typ: Monoclonal
Klon: D45D3
Konjugat: No
Wirt: Rabbit
Spezies-Reaktivität: human, monkey, mouse, rat
Immunogen: Synthetic peptide corresponding to residues surrounding Thr197 of human PKA C.
Format: Supernatant

Handhabung & Sicherheit

Lagerung: -20°C
Versand: +4°C (International: -20°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Anti-phospho-PRKACA, (Thr197) (cAMP-dependent Protein Kinase Catalytic Subunit alpha, PKA C-alpha,"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen